Nov 16, 2023
In this episode, host Shikha Jain, MD, speaks
with Kerry Reynolds, MD, about
immunotherapy-related adverse events, creating educational
resources on immunotherapy management and more.
• Welcome to another exciting episode of Oncology
Overdrive :58
• About Reynolds 1:06
• The interview 2:45
• Tell me about how your journey led you to this field
of immunotherapy-related adverse events?
3:12
• Jain and Reynolds on how immunotherapy has changed
how we talk about cancer care. 5:41
• How did you start the
Severe Immunotherapy Complications Service?
6:16
• When you envision this program, what do you feel are
the short-term and long-term goals?
10:47
• Can you tell me more about how you care for and
manage in-patients through your program?
14:34
• As we learn more, do you think there will ever be a
day where all immunotherapy side effects will be able to be managed
in the outpatient setting? 16:34
• How do people get into this clinic, and what types
of patients are admitted? 18:35
• Tell me about your book,
Facing Immunotherapy: A Guide for Patients and Their Families.
Who is the best audience for this book?
21:35
• Along with this book, are there other educational
resources or initiatives that raise awareness for management of
severe immunotherapy complications?
24:56
• Have you encountered any challenges or obstacles
while creating and maintaining educational resources and research
initiatives? 27:11
• Jain and Reynolds on the progress made in this space
and the road ahead. 29:43
• If someone could only listen to the last two minutes
of this episode, what would you want them to take away?
31:10
• How to contact Reynolds
32:40
• Thanks for listening
33:27
Kerry Reynolds, MD, is an oncologist at the Massachusetts General Hospital Cancer Center and Assistant Professor of Medicine at Harvard Medical School.
We’d love to hear from you! Send your comments/questions to Dr.
Jain at oncologyoverdrive@healio.com.
Follow Healio on X, formerly known as Twitter, and LinkedIn:
@HemOncToday and
https://www.linkedin.com/company/hemonctoday/.
Follow Dr. Jain on X, formerly known as Twitter:
@ShikhaJainMD. Reynolds can be reached at
MGH SIC, or via email kreynolds7@partners.org.
Disclosures: Jain reports no relevant
financial disclosures. Reynolds reports BMS Institutional research
support and is on the advisory board for SAGA Diagnostics.